GlassScriptPhysician profile
Robert B Buechler
NPI 1770566275
$640.99
in general payments reported to CMS, 2019-2025
9 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $269 · 2020: $106 · 2021: $266.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Optinose US, INC. | $190.96 | 2019-2021 | |
| Intersect Ent, INC. | $149.07 | 2021 | |
| Arrinex, INC. | $131.44 | 2019 | |
| Genzyme Corporation | $46.63 | 2019 | |
| Ambu INC. | $43.84 | 2020 | |
| Stryker Corporation | $33.59 | 2019 | |
| Olympus America INC. | $17.79 | 2019 | |
| Aerin Medical INC. | $15.26 | 2020 | |
| Apria Healthcare LLC | $12.41 | 2021 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robert Buechler listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.